New Results
Diagnostic, Infection Timing and Incidence Surveillance Applications of High Dynamic Range Chemiluminescent HIV Immuno-Assay Platforms
View ORCID ProfileEduard Grebe, Alex Welte, Jake Hall, Sheila M. Keating, Shelley N. Facente, Kara Marson, Jeffrey N. Martin, Susan J. Little, Matthew A. Price, Esper G. Kallas, Michael P. Busch, Christopher D. Pilcher, Gary Murphy, on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
doi: https://doi.org/10.1101/132332
Eduard Grebe
1South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa;
PhDAlex Welte
1South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa;
PhDJake Hall
2Public Health England, London, United Kingdom;
BScSheila M. Keating
3Blood Systems Research Institute, San Francisco, CA;
4University of California, San Francisco, San Francisco, CA;
PhD, MSPHShelley N. Facente
4University of California, San Francisco, San Francisco, CA;
MPHKara Marson
4University of California, San Francisco, San Francisco, CA;
MPHJeffrey N. Martin
5University of California, San Diego, San Diego, CA;
PhDSusan J. Little
5University of California, San Diego, San Diego, CA;
MDMatthew A. Price
4University of California, San Francisco, San Francisco, CA;
6Department of Medical Affairs, International AIDS Vaccine Initiative (IAVI), New York City, NY;
PhDEsper G. Kallas
7Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
MD, PhDMichael P. Busch
3Blood Systems Research Institute, San Francisco, CA;
4University of California, San Francisco, San Francisco, CA;
MD, PhDChristopher D. Pilcher
4University of California, San Francisco, San Francisco, CA;
MD, PhDGary Murphy
2Public Health England, London, United Kingdom;
PhDArticle usage
Posted May 03, 2017.
Diagnostic, Infection Timing and Incidence Surveillance Applications of High Dynamic Range Chemiluminescent HIV Immuno-Assay Platforms
Eduard Grebe, Alex Welte, Jake Hall, Sheila M. Keating, Shelley N. Facente, Kara Marson, Jeffrey N. Martin, Susan J. Little, Matthew A. Price, Esper G. Kallas, Michael P. Busch, Christopher D. Pilcher, Gary Murphy, on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
bioRxiv 132332; doi: https://doi.org/10.1101/132332
Diagnostic, Infection Timing and Incidence Surveillance Applications of High Dynamic Range Chemiluminescent HIV Immuno-Assay Platforms
Eduard Grebe, Alex Welte, Jake Hall, Sheila M. Keating, Shelley N. Facente, Kara Marson, Jeffrey N. Martin, Susan J. Little, Matthew A. Price, Esper G. Kallas, Michael P. Busch, Christopher D. Pilcher, Gary Murphy, on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
bioRxiv 132332; doi: https://doi.org/10.1101/132332
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8752)
- Bioinformatics (29201)
- Biophysics (14974)
- Cancer Biology (12100)
- Cell Biology (17413)
- Clinical Trials (138)
- Developmental Biology (9422)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12245)
- Genomics (16804)
- Immunology (11869)
- Microbiology (28098)
- Molecular Biology (11596)
- Neuroscience (60975)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)